Captain Planet is set to return more than three decades since it first broadcast on TV. A new comic book series by Dynamite ...

Editorial cartoons can be as varied and complex as any other piece of journalistic commentary. And while they can and do sometimes evoke a chuckle, they aren’t always supposed to be funny.

Artists take on surgical precision, going under the knife, and more From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox. From ...

years of experience at a multinational biotech in Cambridge, and a stint at a biotech startup in the Boston suburbs.

Biotechnology is a broad discipline in which biological processes, organisms, cells or cellular components are exploited to develop new technologies. New tools and products developed by ...

The company said in a release last month about a human clinical trial that it is “a clinical-stage biotechnology company dedicated to improving the lives of patients suffering from debilitating ...

These summer cartoons are not only funny but also relatable. Like summer memes, they touch on different aspects of summer life, from the iconic barbecues to swimwear shopping and fun times ...

The U.S. biotech sector had already been through a brutal few years before the latest market crash. Robert F. Kennedy Jr.’s shake-up of the nation’s health agencies and persistently high ...

You’re all signed up! Want more of our free, weekly newsletters in your inbox? Let’s get started. The Tampa Bay Times e-Newspaper is a digital replica of the printed paper seven days a ...

After San Francisco biotech company Third Harmonic Bio slashed its staff by half in February, it’s now taking a more drastic step. The inflammatory disease research company’s directors have ...

Former Washington Post cartoonist Ann Telnaes — who resigned in January over the paper spiking a cartoon that depicted the newspaper’s owner, Jeff Bezos, and other tech titans bending the knee ...

He co-founded a biotech company called Variant Bio that has cut revenue-sharing deals with more than 25 Indigenous groups around the world to use their genomes to discover new targets for drugs.